This study provides the first indication that DCIR expression in CD4+ T cells can be promoted by inflammatory and immune hyperactivated conditions since RA is considered as a chronic, systemic inflammatory disorder characterized by a chronic T-cell response that has escaped normal control mechanisms [4], [5]. The gene discussed is CLEC4A; the disease is rheumatoid arthritis.